LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β<sub>1-42</sub> Fibrils

LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β<sub>1-42</sub> Fibrils

Intracerebral accumulation of amyloid-β in the extracellular plaques of Alzheimer’s disease (AD) brains represents the main cause of reactive astrogliosis and neuroinflammatory response. Of relevance, leucine-rich repeat kinase 2 (LRRK2), a kinase linked to genetic and sporadic Parkinson’s disease (...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Alice Filippini, Valentina Salvi, Vincenzo Dattilo, Chiara Magri, Stefania Castrezzati, Robert Veerhuis, Daniela Bosisio, Massimo Gennarelli, Isabella Russo
Format:	Artikel
Sprache:	English
Veröffentlicht:	MDPI AG 2023-02-01
Schriftenreihe:	Biomolecules
Schlagworte:	LRRK2 Alzheimer’s disease astrocytes amyloid-β neuroinflammation
Online Zugang:	https://www.mdpi.com/2218-273X/13/2/307

Ähnliche Einträge

LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer’s and Parkinson’s Disease-Related Neuroinflammation
von: Veronica Mutti, et al.
Veröffentlicht: (2023-07-01)

Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice
von: Ye Zhao, et al.
Veröffentlicht: (2018-12-01)

Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors
von: Dong Hwan Ho, et al.
Veröffentlicht: (2024-05-01)

The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms
von: Sidhanth Chandra, et al.
Veröffentlicht: (2023-07-01)

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
von: Diego Cabezudo, et al.
Veröffentlicht: (2020-04-01)

Gentiacaulein inhibits glucose transport to induce PRKAA1-mediated autophagy to clear amyloid beta and associated inflammation in primary astrocytes
von: Ankita Sharma, et al.
Veröffentlicht: (2024-12-01)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
von: Heather D.E. Booth, et al.
Veröffentlicht: (2019-09-01)

Small heterodimer partner (SHP) aggravates ER stress in Parkinson’s disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation
von: Jee Hoon Lee, et al.
Veröffentlicht: (2021-07-01)

Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
von: Deepali Singh
Veröffentlicht: (2022-08-01)

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
von: Jee Hoon Lee, et al.
Veröffentlicht: (2019-05-01)

Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 <i>Drosophila</i> Models
von: Hoai Nam Nguyen, et al.
Veröffentlicht: (2024-07-01)

Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
von: Marta Valenza, et al.
Veröffentlicht: (2021-04-01)

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
von: Isabella Russo, et al.
Veröffentlicht: (2019-09-01)

The role of astrocytes in amyloid production and Alzheimer's disease
von: Georgia R. Frost, et al.
Veröffentlicht: (2017-01-01)

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
von: Monica Xiong, et al.
Veröffentlicht: (2023-03-01)

Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer’s disease
von: Qian Yue, et al.
Veröffentlicht: (2023-01-01)

α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
von: Taraneh Ebrahimi, et al.
Veröffentlicht: (2018-09-01)

Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
von: Kaela Kelly, et al.
Veröffentlicht: (2020-08-01)

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
von: Dayne A Beccano-Kelly, et al.
Veröffentlicht: (2014-09-01)

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
von: Joanna A. Korecka, et al.
Veröffentlicht: (2020-09-01)

Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants
von: Sanghoon Kim, et al.
Veröffentlicht: (2023-02-01)

Polar lipids modify Alzheimer’s Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation
von: Sakshi Hans, et al.
Veröffentlicht: (2024-04-01)

Cortical superficial siderosis is associated with reactive astrogliosis in cerebral amyloid angiopathy
von: Corinne A. Auger, et al.
Veröffentlicht: (2023-08-01)

LRRK2 as a target for modulating immune system responses
von: Isabella Russo, et al.
Veröffentlicht: (2022-07-01)

The Role of Astrocytes and Blood–Brain Barrier Disruption in Alzheimer’s Disease
von: João Victor R. Cruz, et al.
Veröffentlicht: (2023-08-01)

Astrocytes and Tinnitus
von: Paola Perin, et al.
Veröffentlicht: (2024-11-01)

Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging
von: Francesco Longo, et al.
Veröffentlicht: (2014-11-01)

β-Amyloid Peptides Are Cytotoxic to Astrocytes in Culture: A Role for Oxidative Stress
von: Begoña Brera, et al.
Veröffentlicht: (2000-08-01)

Impact of Aβ40 and Aβ42 Fibrils on the Transcriptome of Primary Astrocytes and Microglia
von: Xiaoyue Zhu, et al.
Veröffentlicht: (2022-11-01)

Amyloid-β 25-35 Induces Neurotoxicity through the Up-Regulation of Astrocytic System X<sub>c</sub><sup>−</sup>
von: Veronica D’Ezio, et al.
Veröffentlicht: (2021-10-01)

Generalized dystonia without Parkinsonism in an LRRK2 carrier
von: Lola Díaz-Feliz, et al.
Veröffentlicht: (2022-01-01)

Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation
von: Jill A. White, et al.
Veröffentlicht: (2005-04-01)

Mutated LRRK2 induces a reactive phenotype and alters migration in human iPSC-derived pericyte-like cells
von: Sanni Peltonen, et al.
Veröffentlicht: (2024-11-01)

Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2
von: Iqra Nazish, et al.
Veröffentlicht: (2023-12-01)

The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related Synapse Dysfunction in Early Alzheimer’s Disease
von: Cong Liu
Veröffentlicht: (2022-06-01)

Sinomenine inhibits amyloid beta-induced astrocyte activation and protects neurons against indirect toxicity
von: Deepali Singh, et al.
Veröffentlicht: (2020-03-01)

LRRK2 kinase activity is necessary for development and regeneration in Nematostella vectensis
von: Grace Holmes, et al.
Veröffentlicht: (2024-08-01)

Roles of neuropathology-associated reactive astrocytes: a systematic review
von: Jill M. Lawrence, et al.
Veröffentlicht: (2023-03-01)

Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence
von: Nasia Dai, et al.
Veröffentlicht: (2022-11-01)

Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish
von: Alice Filippini, et al.
Veröffentlicht: (2024-07-01)